About
Awards
History
Leadership
Board of Directors
Investors and Partners
Pipeline
Cefepime-Taniborbactam
Ceftibuten-Ledaborbactam Etzadroxil
PBP Inhibitor
Publications
Manuscripts
Conference Presentations
News & Events
Press Releases
In the News
Events
Careers
Open Positions
#venatorxcares
Contact
Publications
Publications
Manuscripts
Conference Presentations
Manuscripts
ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant
Pseudomonas aeruginosa
to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime
Examining the activity of cefepime-taniborbactam against
Burkholderia cepacia
complex and
Burkholderia gladioli
isolated from cystic fibrosis patients in the United States
MORE MANUSCRIPTS
Conference Presentations
Evaluation of Single and Multiple Dose Safety and Pharmacokinetics of Ledaborbactam Etzadroxil and Ceftibuten-Ledaborbactam Etzadroxil in Healthy Volunteers
In vitro activity of ceftibuten-ledaborbactam and comparators against Enterobacterales from a Phase 3 study of adults with complicated urinary tract infection (cUTI)
Outcomes at Test of Cure by baseline pathogen and cefepime-taniborbactam or meropenem MIC in the Phase 3 CERTAIN-1 study of patients with complicated urinary tract infection (cUTI)
In Vitro
Activity of Cefepime-Taniborbactamand Comparator Agents Against Gram-Negative Bacteria Isolated from Patients with Cancer
MORE CONFERENCE PRESENTATIONS
You are using a browser that is not supported. Please consider changing your browser
